Literature DB >> 15596061

Ctla4 and multiple sclerosis in the Italian population.

G Malferrari1, A Stella, E Monferini, G Saltini, M C Proverbio, L M Grimaldi, L Rossi-Bernardi, I Biunno.   

Abstract

CTLA4 protein is a receptor molecule that plays a critical role as a negative regulator of the immune response. Therefore, genetic variations in CTLA4 may confer susceptibility to autoimmune diseases such as multiple sclerosis (MS). In order to investigate the association of two CTLA4 polymorphisms (+49 A/G and -318 C/T) with multiple sclerosis, sporadic MS patients and healthy controls from Italy were genotyped through direct DNA sequencing. Considering single-loci variations, no differences in the allelic and genotypic frequencies between patients and controls were found. However, considering a putative interaction at the two loci, the T/G combination was more frequently observed in patients than in controls. This result suggests that this allelic combination of the CTLA4 polymorphisms may be involved in the susceptibility to MS in the Italian population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596061     DOI: 10.1016/j.yexmp.2004.10.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  7 in total

1.  Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele.

Authors:  Bernadett Farago; Peter Kisfali; Lili Magyari; Noemi Polgar; Bela Melegh
Journal:  Autoimmune Dis       Date:  2009-08-27

2.  Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.

Authors:  G Balbi; F Ferrera; M Rizzi; P Piccioli; A Morabito; L Cardamone; M Ghio; G L Palmisano; P Carrara; S Pedemonte; M Sessarego; M De Angioletti; R Notaro; F Indiveri; M P Pistillo
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

3.  The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.

Authors:  Lidia Karabon; Agata Kosmaczewska; Malgorzata Bilinska; Edyta Pawlak; Lidia Ciszak; Anna Jedynak; Anna Jonkisz; Leszek Noga; Anna Pokryszko-Dragan; Magdalena Koszewicz; Irena Frydecka
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

4.  T regulatory cells are markers of disease activity in multiple sclerosis patients.

Authors:  Dacia Dalla Libera; Diletta Di Mitri; Alessandra Bergami; Diego Centonze; Claudio Gasperini; Maria Grazia Grasso; Simona Galgani; Vittorio Martinelli; Giancarlo Comi; Carlo Avolio; Gianvito Martino; Giovanna Borsellino; Federica Sallusto; Luca Battistini; Roberto Furlan
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

5.  Family Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple Sclerosis.

Authors:  O Yu Makarycheva; E Yu Tsareva; M A Sudomoina; O G Kulakova; B V Titov; O V Bykova; N V Gol'tsova; L M Kuzenkova; A N Boiko; O O Favorova
Journal:  Acta Naturae       Date:  2011-01       Impact factor: 1.845

6.  Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis.

Authors:  Xiao Haibing; Cao Xu; Cai Jifu; Zeng Wenshuang; Li Ling; Cui Yuzhen; Hu Yanjun
Journal:  Open Med (Wars)       Date:  2016-07-22

Review 7.  The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis.

Authors:  Maria Sofia Basile; Placido Bramanti; Emanuela Mazzon
Journal:  Genes (Basel)       Date:  2022-07-24       Impact factor: 4.141

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.